Xian‐Chao Cheng

Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.

Xian‐Chao Cheng, Qiang Wang, Hao Fang et al. · PubMed · 2008 · 72 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Role of Sulfonamide Group in Matrix Metalloproteinase Inhibitors

Xian‐Chao Cheng, Qiang Wang, Hao Fang et al. · Current Medicinal Chemistry · 2008 · 64 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Design, synthesis, and biological activities of novel Ligustrazine derivatives

Xian‐Chao Cheng, Xinyong Liu, Wenfang Xu et al. · Bioorganic & Medicinal Chemistry · 2007 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Synthesis of Novel Derivatives of 4-Amino-3-(2-Furyl)-5-Mercapto-1,2,4-Triazole as Potential HIV-1 NNRTIs

Jingde Wu, Xinyong Liu, Xian‐Chao Cheng et al. · Molecules · 2007 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus

Shuqing Wang, Xian‐Chao Cheng, Wei‐Li Dong et al. · Biochemical and Biophysical Research Communications · 2010 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14